BUY MBP SOFOSBUVIR 400MG & VELPATASVIR 100MG VELPACLEAR 400MG+ 100MG TAB BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Medicine name: Sofosbuvir 400 mg and velpatasvir 100 mg
Brand name: Epclusa or generic equivalent

I would like to explain your medicine called sofosbuvir 400 mg and velpatasvir 100 mg in detail so you clearly understand why sofosbuvir 400 mg and velpatasvir 100 mg has been prescribed, how sofosbuvir 400 mg and velpatasvir 100 mg works, how to take sofosbuvir 400 mg and velpatasvir 100 mg correctly, and the important safety points while you are taking sofosbuvir 400 mg and velpatasvir 100 mg. Please take your time with this information and ask questions if anything is unclear.

Sofosbuvir 400 mg and velpatasvir 100 mg is a fixed-dose combination antiviral medicine used to treat chronic hepatitis C infection. Hepatitis C is a virus that affects the liver and can cause long-term inflammation, liver scarring known as cirrhosis, liver failure, or liver cancer if left untreated. Sofosbuvir 400 mg and velpatasvir 100 mg works by directly stopping the hepatitis C virus from multiplying. When taken correctly, sofosbuvir 400 mg and velpatasvir 100 mg can cure hepatitis C in the vast majority of patients.

Sofosbuvir 400 mg and velpatasvir 100 mg contains two antiviral medicines that work together at different stages of the viral life cycle. Sofosbuvir blocks an enzyme the virus needs to make copies of itself, while velpatasvir blocks a protein the virus needs to assemble and survive. By attacking the virus in two ways, sofosbuvir 400 mg and velpatasvir 100 mg provides very strong viral suppression and allows the immune system to clear the infection completely.

Sofosbuvir 400 mg and velpatasvir 100 mg is effective against all major hepatitis C genotypes, which means it can be used in most patients regardless of the virus type. The usual treatment duration with sofosbuvir 400 mg and velpatasvir 100 mg is 12 weeks, although this may vary in people with advanced liver disease or previous treatment failure.

Sofosbuvir 400 mg and velpatasvir 100 mg is taken by mouth once daily. Sofosbuvir 400 mg and velpatasvir 100 mg can be taken with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. Taking sofosbuvir 400 mg and velpatasvir 100 mg at the same time each day helps maintain steady drug levels and maximises the chance of cure.

If you miss a dose of sofosbuvir 400 mg and velpatasvir 100 mg and remember on the same day, take the dose as soon as you remember. If it is close to the time of your next dose, skip the missed dose and take the next dose at the usual time. Do not take two doses of sofosbuvir 400 mg and velpatasvir 100 mg at the same time. Missing doses of sofosbuvir 400 mg and velpatasvir 100 mg can reduce treatment effectiveness.

Sofosbuvir 400 mg and velpatasvir 100 mg is generally very well tolerated. Common side effects include tiredness, headache, nausea, difficulty sleeping, and mild stomach discomfort. These side effects are usually mild and temporary, and most people are able to complete treatment with sofosbuvir 400 mg and velpatasvir 100 mg without difficulty.

A very important safety consideration with sofosbuvir 400 mg and velpatasvir 100 mg is interaction with certain heart medicines, especially amiodarone. Taking amiodarone with sofosbuvir-containing medicines can cause dangerously slow heart rate. You must inform your healthcare provider if you are taking amiodarone or have any heart rhythm problems before starting sofosbuvir 400 mg and velpatasvir 100 mg.

Sofosbuvir 400 mg and velpatasvir 100 mg can also interact with medicines that reduce stomach acid, such as proton pump inhibitors, H2 blockers, and antacids. Reduced stomach acid can lower absorption of velpatasvir. Your healthcare provider may give you specific instructions on spacing acid-reducing medicines if they are required while taking sofosbuvir 400 mg and velpatasvir 100 mg.

Regular blood tests are arranged during and after treatment with sofosbuvir 400 mg and velpatasvir 100 mg. These tests monitor liver function and confirm that the hepatitis C virus has been cleared. Blood tests after completing sofosbuvir 400 mg and velpatasvir 100 mg are essential to confirm cure.

It is very important to complete the full course of sofosbuvir 400 mg and velpatasvir 100 mg even if you feel well. Stopping sofosbuvir 400 mg and velpatasvir 100 mg early or missing multiple doses can allow the virus to return and reduce the chance of cure.

Sofosbuvir 400 mg and velpatasvir 100 mg does not protect against re-infection with hepatitis C. It is important to continue safe practices to avoid exposure to the virus after treatment.

Sofosbuvir 400 mg and velpatasvir 100 mg may be used during pregnancy or breastfeeding only after careful specialist assessment. Always inform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding before or during treatment with sofosbuvir 400 mg and velpatasvir 100 mg.

In summary, sofosbuvir 400 mg and velpatasvir 100 mg is a highly effective, well-tolerated antiviral medicine that can cure hepatitis C when taken correctly. Safe and effective use of sofosbuvir 400 mg and velpatasvir 100 mg depends on taking sofosbuvir 400 mg and velpatasvir 100 mg once daily without missing doses, completing the full treatment course, attending all blood test appointments, and checking for medicine interactions. If you have any concerns or questions about sofosbuvir 400 mg and velpatasvir 100 mg at any stage of treatment, please raise them so they can be addressed promptly and safely.